Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production.

Abstract

Viral protein glycosylation represents a successful strategy employed by the parasite to take advantage of host-cell machinery for modification of its own proteins. The resulting glycans have unneglectable roles in viral infection and immune response. The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which presents on the surface of matured virion and mediates viral entry into the host, also undergoes extensive glycosylation to shield it from the human defense system. It is believed that the ongoing COVID-19 pandemic with more than 90,000,000 infections and 1,900,000 deaths is partly due to its successful glycosylation strategy. On the other hand, while glycan patches on S protein have been reported to shield the host immune response by masking "nonself" viral peptides with "self-glycans," the epitopes are also important in eliciting neutralizing antibodies. In this review, we will summarize the roles of S protein glycans in mediating virus-receptor interactions, and in antibody production, as well as indications for vaccine development.

• Authors: Xiaohui Zhao, Huan Chen, Hongliang Wang
• Journal: Frontiers in molecular biosciences (Front Mol Biosci) Vol. 8 Pg. 629873 ( 2021) ISSN: 2296-889X [Print] Switzerland
• PMID: 33928117 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2021 Zhao, Chen and Wang.